UK
UK
Aug-17
Mental Health Neurology Pharmacoepidemiology
Read moreAug-17
Geriatrics Mental Health Neurology Pharmacoepidemiology
Read moreAug-17
Cardiovascular Pharmacoepidemiology
Read moreAug-17
Endocrinology Geriatrics Pharmacoepidemiology
Read moreAug-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreAug-17
Aug-17
Other Vascular Pharmacoepidemiology
Read moreAug-17
Gastroenterology Pharmacoepidemiology
Read moreJul-17
Cardiovascular Pharmacoepidemiology
Read moreJul-17
Gastroenterology Musculoskeletal Pharmacoepidemiology Respiratory
Read moreJul-17
Endocrinology Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Aug-17 | Antipsychotic Utilization Patterns in a Cohort of 1.5 Million Schizophrenic Patients. A Cross‐National Study | Read more | |
| Aug-17 | Assessment of the Effect of Minimization Measures of the Risk of Stroke with Antipsychotic Use in Elderly Persons: A Nested Case‐Control Study | Read more | |
| Aug-17 | Clinical Indications for Fluoroquinolones in Routine Care | Read more | |
| Aug-17 | Comparative Cardiovascular Safety of Strontium Ranelate and Bisphosphonates Amongst Patients with No Contraindications: a Multidatabase Study in our European Countries by the EU-ADR Alliance | Read more | |
| Aug-17 | Comparative Effectiveness of Sitagliptin Compared to Sulphonylureas for Type 2 Diabetes Among Elderly Patients Inadequately Controlled on Metformin | Read more | |
| Aug-17 | Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study | Read more | |
| Aug-17 | Impact of Risk Minimisation Measures on the Use of Strontium Ranelate: A Multi‐National Cohort Study in 5 EU Countries by the EU‐ADR Alliance | Read more | |
| Aug-17 | Impact of Risk Minimization Measures on the Use of Cilostazol in Europe | Read more | |
| Aug-17 | Incidence of Upper and Lower Gastrointestinal Bleeds in New Users and Non‐Users of Low‐Dose Aspirin in the UK | Read more | |
| Jul-17 | Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors) | Read more | |
| Jul-17 | Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study |
Gastroenterology Musculoskeletal Pharmacoepidemiology Respiratory |
Read more |
| Jul-17 | Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes | Read more |
